# The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer

> **NCT06824259** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Follow up if MRI is negative
- **PROCEDURE:** Systematic biopsy if MRI is negative

## Key facts

- **NCT ID:** NCT06824259
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-14
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06824259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06824259, "The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06824259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*